Post

Trials to watch: Phase III BCG naïve non-muscle invasive bladder cancer

In 1980, scientists discovered something rather unexpected – the tuberculosis vaccine, Bacillus Calmette-Guérin (BCG) was effective in reducing the recurrence …

NIH Phase Ib/II DLBCL drug combo trial reports 34% complete response

A five drug combination drug therapy trial has shown substantial tumour shrinking in more than half of patients, with some …

MindBio’s LSD-based drug reduced depression symptoms in Phase IIa trial

Vancouver-headquartered MindBio Therapeutics has announced its Lysergic Acid Diethylamide (LSD) based drug MB22001 has reduced symptoms of depression in a …

Race Oncology engages George Clinical for Phase I solid tumour trial

Race Oncology has engaged contract research organisation (CRO) George Clinical International to support the Phase I clinical trial of RC220 …

Vita Global Sciences to deploy Veeva Vault EDC to modernise trials

CRO Vita Global Sciences has entered a partnership with Veeva Systems to implement Veeva Vault EDC in an effort to …